Full-Time

Head of Discovery

Output Biosciences

Output Biosciences

1-10 employees

AI-driven preventative therapeutics for chronic disease

No salary listed

New York, NY, USA

In Person

PhD

Category
Biology & Biotech (1)
Required Skills
Python
Medicinal Chemistry
Chemical Biology
Pharmacology
Data Analysis

Get referred to Output Biosciences

See people who can refer or advise you

Requirements
  • A PhD in pharmacology, medicinal chemistry, chemical biology, computational biology, or a related field, with 5+ years of drug discovery experience in pharma or biotech, or equivalent depth through extensive industry experience.
  • Hands-on experience advancing drug discovery programs through target selection, hit identification, hit-to-lead, and lead optimization.
  • Demonstrated experience evaluating drug candidates and making scientific go/no-go decisions on real programs.
  • Comfort working directly with computational model outputs and analyzing artificial intelligence-generated molecular data.
  • Strong scientific judgment across target biology, disease mechanisms, and therapeutic modalities.
  • Ability to build and defend a scientific rationale, communicate across disciplines, and make decisions under uncertainty.
Responsibilities
  • Identify and evaluate therapeutic targets, building the scientific rationale for which programs to pursue and why.
  • Analyze model outputs to assess drug candidates, evaluating biological plausibility, therapeutic potential, and readiness for advancement.
  • Prioritize candidates and make scientific go/no-go decisions, advancing the strongest compounds through the discovery pipeline.
  • Manage contract research organization partnerships for candidate synthesis and biological testing, designing experiments that validate or refine drug design hypotheses.
  • Work closely with the founders and model team, bringing drug discovery expertise to model evaluation and development priorities.
  • Stay current with target biology, disease mechanisms, and the clinical landscape across relevant therapeutic areas.
Desired Qualifications
  • Experience with AI-driven drug discovery or computational drug design tools.
  • Experience managing contract research organization relationships for synthesis and biological testing.
  • Experience across multiple therapeutic areas or modalities, including small molecules and peptides.
  • A track record of advancing compounds into preclinical or clinical development.
  • Programming skills in Python, with the ability to work hands-on with data analysis tools and model outputs.
  • Publications at top-tier venues or relevant drug discovery and medicinal chemistry journals.

Output Biosciences develops preventative therapeutics to extend human healthspan by combatting chronic diseases. It uses computational biology and AI to discover therapies that can prevent diseases faster, with safer profiles and easier manufacturing, enabling quicker development timelines. The company differentiates itself by integrating biotech expertise with AI to create therapies focused on prevention, and by forming partnerships with pharmaceutical companies, licensing its technologies, and pursuing direct therapy sales. Its goal is to bring preventive treatments to market within months, shifting drug development toward stopping chronic diseases before they start.

Company Size

1-10

Company Stage

Seed

Total Funding

$130K

Headquarters

New York City, New York

Founded

2020

Get referred to Output Biosciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The July 28, 2026 website says it is still hiring, signaling active execution.
  • LinkedIn jobs in June 2026 listed interpretability and molecular-generation roles, showing technical expansion.
  • Its AI-biology positioning fits investors chasing faster discovery and easier manufacturing.

What critics are saying

  • Funding looks tiny: PitchBook shows $125K raised, and CB Insights shows $500K total.
  • No public clinical asset, partnership, or revenue evidence exists by July 2026.
  • An AI-platform story without drug candidates risks commoditization before meaningful validation.

What makes Output Biosciences unique

  • Output Bio's 2026 website sells biologically-aware generative AI for breakthrough medicines.
  • It targets long, nonlinear biological data with Large Biological Models, not standard chemistry pipelines.
  • Mirella Mashiach has led the company since July 2021, signaling founder continuity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Company Equity